Global Pipettes and Pipettors Market to Reach $2.5 Billion by 2027

NEXT STORY
Teleflex Announces Second Quarter 2021 Earnings Conference Call Information
PREV STORY
2021 Insights on the RNA Therapeutics Global Market – Stability of mRNA Vaccines and RNA Therapeutics at Ambient Temperature Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s phase III EMPACTA study showed Actemra/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumonia

author_avatar
NASDAQ Market News

DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy

author_avatar
NASDAQ Market News

Cellectar Biosciences Reports First Quarter 2017 Financial and Corporate Performance

MADISON, Wis., May 11, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), ...

author_avatar
NASDAQ Market News